Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury

Abstract

DA-8159 is a pyrazolopyrimidinone derivative which exhibits potent and selective phosphodiesterase type 5 (PDE5) inhibition. The aim of this study was to investigate the effects of DA-8159 on inducing a penile erection in rabbits with an acute spinal cord injury (ASCI). DA-8159 was given either orally (1, 3, or 10 mg/kg) or intravenously (0.1 or 0.3 mg/kg) to conscious male albino rabbits with a surgical transection of the spinal cord at the L2–L4 lumbar vertebra or ischemic-reperfusion SCI rabbits. Erection was evaluated in a time-course manner by measuring the length of the uncovered penile mucosa. DA-8159 induced a dose-dependent erection in both transection and ischemic-reperfusion ASCI rabbits. The efficacy of DA-8159 was potentiated by an intravenous injection of sodium nitroprusside, a nitric oxide donor. Potentiation of the effect by nitric oxide donor implies that DA-8159 can enhance the erectile activity during sexual arousal. These results suggest that DA-8159 may be useful for treating erectile dysfunction in patients with an SCI.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Andersson KE, Wagner G . Physiology of penile erection. Physiol Rev 1995; 75: 191–236.

    Article  CAS  PubMed  Google Scholar 

  2. Burnett AL et al. Nitric oxicde: a physiologic mediator of penile erection. Science 1992; 257: 401–405.

    Article  CAS  PubMed  Google Scholar 

  3. Ignarro LJ et al. Nitric oxide and cyclic GMP formation upon electrical stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170: 843–850.

    Article  CAS  PubMed  Google Scholar 

  4. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I . A nitric oxide-like factor mediates nonadrenergic–noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991; 88: 112–118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Azadzoi KM et al. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 1992; 147: 220–225.

    Article  CAS  PubMed  Google Scholar 

  6. Trigo-Rocha F et al. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic noncholinergic neurotransmission in canine penile erection. J Urol 1993; 149: 872–877.

    Article  CAS  PubMed  Google Scholar 

  7. Lugg JA, Gonzales-Cadaved NF, Rajfer J . The role of nitric oxide in erectile function. J Androl 1995; 16: 2–4.

    CAS  PubMed  Google Scholar 

  8. Burnett AL . Nitric oxide in the penis; physiology and pathology. J Urol 1997; 157: 320–324.

    Article  CAS  PubMed  Google Scholar 

  9. Beavo JL . Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725–748.

    Article  CAS  PubMed  Google Scholar 

  10. Ballard SA et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 59: 2164–2171.

    Article  Google Scholar 

  11. Junemann KP, Buhrle CP, Persson-Junemann C . Pathophysio-logy of neurogenic impotence. Sex Disabil 1994; 12: 5–15.

    Article  Google Scholar 

  12. Aloni R et al. Non-invasive treatment for erectile dysfunction in the neurologically disabled population. J Sex Marital Ther 1992; 18: 243–249.

    Article  CAS  PubMed  Google Scholar 

  13. Bodner DR, Haas CA, Krueger B, Seftel AD . Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology 1999; 53: 199–202.

    Article  CAS  PubMed  Google Scholar 

  14. Lloyd LK, Richards JS . Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury. Paraplesia 1989; 27: 457–464.

    CAS  Google Scholar 

  15. Sanchez RA et al. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord 2001; 39: 637–643.

    Article  Google Scholar 

  16. Gans WH et al. Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury. J Spinal Cord Med 2001; 24: 35–40.

    Article  CAS  PubMed  Google Scholar 

  17. Schmid DM, Schurch B, Hauri D . Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients. Eur Urol 2000; 38: 184–193.

    Article  CAS  PubMed  Google Scholar 

  18. Maytom MC et al. A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 1999; 37: 110–116.

    Article  CAS  PubMed  Google Scholar 

  19. Oh TY et al. Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res 2000; 23: 471–476.

    Article  CAS  PubMed  Google Scholar 

  20. Doh H et al. Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res 2002; 25: 873–878.

    Article  CAS  PubMed  Google Scholar 

  21. Tetik O et al. An intraaortic solution trial to prevent spinal cord injury in a rabbit model. Eur J Vasc Endovasc Surg 2001; 22: 175–179.

    Article  CAS  PubMed  Google Scholar 

  22. Cassada DC et al. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann Thorac Surg 2001; 72: 1245–1250.

    Article  CAS  PubMed  Google Scholar 

  23. Parrino PE et al. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion. Ann Thorac Surg 1999; 67: 1589–1595.

    Article  CAS  PubMed  Google Scholar 

  24. Agee JM et al. Reducing postischemic paraplesia using conjugated superoxide dismutase. Ann Thorac Surg 1991; 51: 911–915.

    Article  CAS  PubMed  Google Scholar 

  25. Herold JA et al. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine. J Thorac Cardiovasc Surg 1994; 107: 536–542.

    CAS  PubMed  Google Scholar 

  26. Okita Y et al. Repair of aneurysm of the entire descending thoracic aorta or thoracoabdominal aorta using a deep hypothermia. Eur J Cardio-thorac Surg 1997; 12: 120–126.

    Article  CAS  Google Scholar 

  27. Simpson JI et al. Intrathecal magnesium sulfate protects the spinal cord from ischemic injury thoracic aortic cross-clamping. Anesthesiology 1994; 81: 1493–1499.

    Article  CAS  PubMed  Google Scholar 

  28. Comarr AE . Sexuality and fertility among spinal cord and/or cauda equine injuries. J Am Paraplesia Soc 1985; 8: 67–75.

    Article  CAS  Google Scholar 

  29. Sonda LP, Mazo R, Chancellor MB . The role of yohimbine for the treatment of erectile impotence. J Sex Marital Therap 1990; 16: 15–21.

    Article  CAS  Google Scholar 

  30. Rivas DA et al. Erectile response to topical, intrurethral and intracorporal pharmacotherapy in a rat model of spinal cord injury. J Spinal Cord Med 1995; 18: 145–150.

    Article  Google Scholar 

  31. Aydin S et al. Effects of sildenafil citrate, acethylcholine, and sodium nitroprusside on the relaxation of rabbit cavernosal tissue in vitro. Urology 2001; 58: 119–124.

    Article  CAS  PubMed  Google Scholar 

  32. Brown JH, Taylor P . Muscarinic receptor agonists and antagonist. In: Hardman JC et al (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill professional, New York, 1995, pp 141–160.

    Google Scholar 

  33. Giuliano F et al. Sildenafil citrate (VIAGRA): a novel oral treatment for erectile dysfunction caused by traumatic spinal cord injury. Int J Clin Pract Suppl 1999; 102: 24–26.

    CAS  PubMed  Google Scholar 

  34. Hall ED, Wolf DL . Pharmacological analysis of the pathophysiological mechanism of post-traumatic spinal cord ischemia. J Neurosurg 1986; 64: 951–961.

    Article  CAS  PubMed  Google Scholar 

  35. Hall ED, Wolf DL . Neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992; 76: 13–22.

    Article  CAS  PubMed  Google Scholar 

  36. Rahman A et al. Neuroprotective effect of regional carnitine on spinal cord ischemia–reperfusion injury. Eur J Cardiothorac Surg 2001; 20: 65–70.

    Article  CAS  PubMed  Google Scholar 

  37. Tai C, Booth AM, de Groat WC, Roppolo JR . Penile erection produced by microstimulation of the sacral spinal cord of the cat. IEEE Trans Rehabil Eng 1998; 6: 374–381.

    Article  CAS  PubMed  Google Scholar 

  38. Mautes AEM, Weinzierl MR, Donovan F, Noble LJ . Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000; 80: 673–687.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y-S Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, B., Kang, K., Ahn, G. et al. Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury. Int J Impot Res 15, 405–411 (2003). https://doi.org/10.1038/sj.ijir.3901055

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901055

Keywords

This article is cited by

Search

Quick links